Chapter 3 - CHLOE HAD BEEN INVESTIGATING HER OWN COMPANY
My attorney arrived at 7:40 a.m.
Nathan Chen.
Fifty-one.
Corporate litigator.
No dramatic personality.
Exactly what I needed.
I showed him Preston’s messages.
The lawyer’s warning.
The flash drive.
Nathan stared at me.
“Did you copy this?”
“Not yet.”
“Do that first.”
Good.
We created three encrypted copies.
One remained with Nathan.
One went into secure cloud storage.
One went to an outside forensic firm.
Only then did we open the drive properly.
Chloe had organized everything.
Of course she had.
My wife alphabetized spices.
The first folder contained clinical-trial summaries.
VX-17 was not supposed to be a sedative.
It was designed as an emergency neuroprotective compound for catastrophic blood loss and trauma.
The idea sounded almost miraculous:
Reduce metabolic demand.
Preserve organs longer.
Give surgeons more time.
Military applications.
Emergency medicine.
Organ transplant.
The market potential was enormous.
So were the problems.
In early trials, some patients developed:
Profound bradycardia.
Respiratory suppression.
Temporary absence of obvious reflexes.
Extended unconsciousness.
Four trial participants had experienced episodes serious enough to require emergency resuscitation.
Two died.
Public reports described the deaths as complications of their original trauma.
Internal reports were different.
One scientist wrote:
Drug effect cannot reasonably be excluded.
Another:
Current monitoring standards insufficient to distinguish expected suppression from terminal deterioration in certain settings.
I looked at Nathan.
“They knew.”
“Somebody knew.”
Then we opened the next folder.
Emails.
Chloe to Eleanor:
We cannot submit the amended FDA package without disclosing the suppression events.
Eleanor:
The events were adjudicated.
Chloe:
By a committee Preston selected.
Eleanor:
Be careful what you imply.
Chloe:
I’m not implying anything.
Then another.
Chloe to Preston:
You moved three serious adverse events out of the primary data set.
Preston:
You’re not a scientist.
Chloe:
Neither are you.
Preston:
I’m the COO.
Chloe:
Then act like one.
I nearly smiled.
That was Chloe.
Then:
Preston:
If VX-17 is delayed again, Halcyon walks.
Halcyon.
The acquisition.
Vanguard had been negotiating a multibillion-dollar strategic partnership with Halcyon Biomed.
I knew that much.
Chloe hated discussing work at home, but she had mentioned the deal could “change the company forever.”
Now I understood why.
VX-17 was the centerpiece.
If the adverse-event data became public before Monday’s board vote, Halcyon could suspend the transaction.
Vanguard’s share price could collapse.
Regulators could open investigations.
Executives could face personal exposure.
Monday.
Two days away.
Chloe had supposedly died Friday.
Funeral Tuesday.
That timing seemed strange.
Until Nathan opened the corporate governance folder.
Chloe owned 21 percent of Vanguard voting shares through a family structure.
Eleanor controlled 18 percent.
Preston 11.
Other family trusts and institutional holders made up the rest.
Chloe had been preparing to vote against the Halcyon transaction unless VX-17 was independently reviewed.
But if Chloe died?
Her voting shares did not pass to me.
Chloe had made sure of that years earlier.
They moved into a testamentary trust for our child.
Until the child reached adulthood, temporary voting authority would be exercised by three trustees.
One was independent.
One was Chloe’s chosen outside counsel.
The third?
Eleanor.
I stared.
Nathan read faster.
“There’s a pregnancy contingency.”
“What?”
“If the child does not survive Chloe by thirty days, those shares revert into the Vanguard Family Governance Trust.”
“Controlled by?”
“You know.”
Eleanor.
My stomach turned.
If Chloe and our daughter were both dead, Eleanor consolidated enough voting power to force the Halcyon transaction through.
Maybe this was motive.
Maybe.
Then Nathan held up one hand.
“Don’t jump.”
“What?”
“This proves financial incentive.”
“It proves—”
“Not murder.”
I hated him.
He was right.
Then we found Chloe’s audio diary.
Timestamp:
Three days before her supposed death.
Her voice filled the room.
Calm at first.
“Liam, if you’re hearing this, something went wrong.”
I stopped breathing.
“I need you to listen all the way through before you do anything.”
Typical Chloe.
Even from an encrypted drive, she was managing me.
“I found evidence that Preston concealed VX-17 adverse events. I confronted Mom. She told me I was confusing ethics with loyalty.”
My hands tightened.
“Yesterday, someone accessed my medical chart from a Vanguard executive network.”
Nathan looked at me.
Chloe continued.
“I’m thirty-four weeks pregnant. There is no legitimate reason anyone at corporate needs my obstetric medication list.”
I felt cold.
“I changed my healthcare proxy today. Liam is primary. Dr. Sarah Monroe is backup. Mom has no authority.”
Nathan immediately searched the drive.
There it was.
Signed.
Notarized.
Healthcare directive.
“Why didn’t the hospital have it?”
I asked.
Nathan’s face hardened.
“Good question.”
Then Chloe:
“I also discovered Preston requested information about VX-17 metabolism during pregnancy.”
My chest stopped.
“He claimed it was theoretical.”
Pause.
“I don’t believe him.”
Then the final words:
“If anything happens to me, Liam… do not trust my mother.”
The recording ended.
I sat in silence.
Nathan did not speak.
Then my phone rang.
Hospital.
I answered instantly.
“Mr. Reynolds?”
“Yes.”
“This is Dr. Ellison.”
My chest tightened.
“What happened?”
“We need to deliver your daughter.”
“Now?”
“Yes.”
“And Chloe?”
“She is unstable.”
I stood.
“Can I see her?”
“For one minute.”
I entered Chloe’s room wearing a gown and mask.
Machines everywhere.
My wife looked nothing like the woman in the coffin.
No mortuary makeup.
No black silk.
Just Chloe.
Pale.
Intubated.
Alive.
I touched her hand.
“Hey.”
Nothing.
“Our little girl is causing trouble.”
My voice broke.
“Clearly yours.”
I kissed Chloe’s fingers.
Then:
“I found it.”
No response.
“I found the drive.”
Still nothing.
“I’m not going to do anything stupid.”
A monitor beeped.
I laughed through tears.
“Okay. Nothing exceptionally stupid.”
A nurse touched my shoulder.
Time.
As I turned, Chloe’s finger moved.
Tiny.
Maybe reflex.
Maybe not.
I froze.
“Chloe?”
Nothing.
Then they rolled her toward surgery.
Thirty-seven minutes later, our daughter was born.
Four pounds, eleven ounces.
Breathing with assistance.
Furious.
Alive.
The nurse asked if we had chosen a name.
I could barely speak.
Chloe and I had.
“Olivia.”
Then I corrected myself.
“No.”
The nurse waited.
Chloe had changed her mind a week before everything happened.
I remembered her laughing in the nursery.
“She’s too stubborn to be an Olivia.”
The name Chloe wanted at the end:
“Grace.”
The nurse smiled.
“Grace Reynolds.”
I stared through the NICU glass at my tiny daughter.
My wife was still unconscious.
My mother-in-law wanted access.
My brother-in-law wanted silence.
And Monday morning, a board intended to vote on a drug that had nearly turned a living pregnant woman into a corpse.
I called Nathan.
“Send the files.”
“To who?”
“The independent directors.”
“Anyone else?”
I looked at Grace.
“Yes.”
“Regulators.”
May you like
That was when the Vanguard family stopped being a family problem.
---
Related Stories
